Page 6 - Project Baseline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Google sister Verily was touted early in the pandemic as a promising coronavirus testing option.

Share Otsuka Pharmaceutical and Click Therapeutics have announced the launch of a new, fully remote clinical trial being conducted on Verily's Project Baseline platform. Called the Mirai study, it will be measuring a digital therapeutics intervention's effectiveness in reducing symptoms of depression among adults who have a major depressive disorder (MDD) diagnosis and are on antidepressant monotherapy. Christoph Koenen, EVP and chief medical officer of Ostuka Pharmaceutical Companies U.S., told MobiHealthNews that the pivotal, randomized, controlled trial will enroll as many as 540 pa...

Gmail finally reveals all data it collects from phone users, adds privacy labels to iOS app After YouTube, Gmail now becomes the second most important Google app to get a privacy label. Ankita Chakravarti | February 23, 2021 | Updated 09:17 IST Highlights Google took a very long time to add labels to its major apps. After YouTube, Gmail now becomes the second most important Google app to get a privacy label. Google has finally added privacy labels to the Gmail app on Apple App Store. Google took a very long time to add labels to its major apps. After YouTube, Gmail now becomes the second m...

The platform's creation, says Anthony Philippakis, chief data officer at the Broad Institute, was driven by two trends within the wider biomedical space: an explosion in the volume and types of data available – from genomics data to medical imaging and electronic health records – alongside a greater need for data sharing within biomedical science. SEE: (TechRepublic) "No one organisation, whether it be a medical centre, or a university, or a company, has enough data in order to go after profound questions like the genetic basis of the disease," he says. "For a long time, although we've ...

Verily joins with Janssen, adding Covid-19 to Project Baseline study Verily and Janssen say studying Covid-19 immune responses could yield data that helps clinicians treat the disease. They add that the research could also apply to other illnesses caused by respiratory pathogens. Shares0   When Verily unveiled $700 million in funding late last year, it said the cash would support its Covid-19 research. Some of those research plans are now taking shape. Verily, the life sciences division of Google parent company Alphabet, is adding Covid-19 to Project Baseline, an expansive study collecting ...